The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
Open accessAbstract
BACKGROUND: Antibodies against HLA antigens cause refractory allograft rejection with vasculopathy in some, but not all, patients. METHODS: We studied 33 kidney-transplant recipients who had refractory vascular rejection. Thirteen had donor-specific anti-HLA antibodies, whereas 20 did not. Malignant hypertension was present in 16 of the patients without anti-HLA antibodies, 4 of whom had seizures. The remaining 17 patients had no malignant hypertension. We hypothesized that activating antibodies targeting the angiotensin II type 1 (AT1) receptor might be involved. RESULTS: Activating IgG antibodies targeting the AT1 receptor were detected in serum from all 16 patients with malignant hypertension and without anti-HLA antibodies, but in no other patients. These receptor-activating antibodies are subclass IgG1 and IgG3 antibodies that bind to two different epitopes on the second extracellular loop of the AT1 receptor. Tissue factor expression was increased in renal-biopsy specimens from patients with these antibodies. In vitro stimulation of vascular cells with an AT1-receptor-activating antibody induced phosphorylation of ERK 1/2 kinase and increased the DNA binding activity of the transcription factors activator protein 1 (AP-1) and nuclear factor-kappaB. The AT1 antagonist losartan blocked agonistic AT1-receptor antibody-mediated effects, and passive antibody transfer induced vasculopathy and hypertension in a rat kidney-transplantation model. CONCLUSIONS: A non-HLA, AT1-receptor-mediated pathway may contribute to refractory vascular rejection, and affected patients might benefit from removal of AT1-receptor antibodies or from pharmacologic blockade of AT1 receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Banff 97 working classification of renal allograft pathology
Racusen, L. C., Solez, K., Colvin, R. B., Bonsib, S. M., Castro, M. C., Cavallo, T., Croker, B. P., Demetris, A. J., Drachenberg, C. B., Fogo, A. B., et al. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00299.x · Cited by 3,033
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
de Gasparo, M., Catt, K. J., Inagami, T., Wright, J. W., & Unger, T. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01458-3 · Cited by 2,132
Self-citationRacusen, L. C., Colvin, R. B., Solez, K., Mihatsch, M. J., Halloran, P. F., Campbell, P. M., Cecka, M. J., Cosyns, J., Demetris, A. J., Fishbein, M. C., et al. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00072.x · Cited by 1,060
Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor
Wallukat, G., Homuth, V., Fischer, T., Lindschau, C., Horstkamp, B., Jüpner, A., Baur, E., Nissen, E., Vetter, K., Neichel, D., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4106 · Cited by 826
Self-citationMauiyyedi, S., Crespo, M., Collins, A. B., Schneeberger, E. E., Pascual, M. A., Saidman, S. L., Tolkoff-Rubin, N. E., Williams, W. W., Delmonico, F. L., Cosimi, A. B., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v133779 · Cited by 492
Baeuerle, P. A. (1998) · Cell · doi:10.1016/s0092-8674(00)81694-3 · Cited by 438
Proinflammatory actions of angiotensins
Ruiz-Ortega, M., Lorenzo, O., Suzuki, Y., Rupérez, M., & Egido, J. (2001) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200105000-00005 · Cited by 412
Magnusson, Y., Wallukat, G., Waagstein, F., Hjalmarson, A., & Hoebeke, J. (1994) · Circulation · doi:10.1161/01.cir.89.6.2760 · Cited by 347
Self-citationBo[Combining Diaeresis]hmig, G. A., Exner, M., Habicht, A., Schillinger, M., Lang, U., Kletzmayr, J., Sa[Combining Diaeresis]emann, M. D., Ho[Combining Diaeresis]rl, W. H., Watschinger, B., & Regele, H. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1341091 · Cited by 340
Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
Nataraj, C., Oliverio, M. I., Mannon, R. B., Mannon, P. J., Audoly, L. P., Amuchastegui, C. S., Ruiz, P., Smithies, O., & Coffman, T. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7451 · Cited by 308
Immunology at the Maternal-Fetal Interface: Lessons for T Cell Tolerance and Suppression
Mellor, A. L., & Munn, D. H. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.367 · Cited by 286
Humoral Antibodies in Renal Allotransplantation in Man
Jeannet, M., Pinn, V. W., Flax, M. H., Winn, H. J., & Russell, P. S. (1970) · New England Journal of Medicine · doi:10.1056/nejm197001152820301 · Cited by 230
Dechend, R., Homuth, V., Wallukat, G., Kreuzer, J., Park, J. K., Theuer, J., Juepner, A., Gulba, D. C., Mackman, N., Haller, H., et al. (2000) · Circulation · doi:10.1161/01.cir.101.20.2382 · Cited by 230
Self-citationWALLUKAT, G., WOLLENBERGER, A., MORWINSKI, R., & PITSCHNER, H. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(08)80036-3 · Cited by 192
Self-citationRapoport, B., & McLachlan, S. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14321 · Cited by 175
Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice
Hisada, Y., Sugaya, T., Yamanouchi, M., Uchida, H., Fujimura, H., Sakurai, H., Fukamizu, A., & Murakami, K. (1999) · Journal of Clinical Investigation · doi:10.1172/jci2454 · Cited by 152
Schwimmbeck, P. L., Dyrberg, T., Drachman, D. B., & Oldstone, M. B. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114282 · Cited by 141
Thway, T. M., Shlykov, S. G., Day, M.-C., et al. (2004) · Circulation · doi:10.1161/01.cir.0000142855.68398.3a · Cited by 129
Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II
Miller, J., Thai, K., & Scholey, J. W. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00770.x · Cited by 126
Control of dendritic cell differentiation by angiotensin II
Nahmod, K. A., Vermeulen, M. E., Radien, S., Salamone, G. V., Gamberale, R., Fernández‐Calotti, P., Alvarez, A. L., Nahmod, V. E., Giordano, M., & Geffner, J. R. (2003) · The FASEB Journal · doi:10.1096/fj.02-0755fje · Cited by 125
Functional autoimmune epitope on α1-adrenergic receptors in patients with malignant hypertension
Fu, M. L. X., Hjalmarson, Å. C., Herlitz, H., Hilme, E., Hedner, T., Wallukat, G., & Hoebeke, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90456-1 · Cited by 120
Self-citationBas‐Bernardet, S. L., Hourmant, M., Coupel, S., Bignon, J., Soulillou, J., & Charreau, B. L. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00021.x · Cited by 112
NFκB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts
Vos, I. H. C., Govers, R., Gröne, H., Kleij, L., Schurink, M., de Weger, R. A., Goldschmeding, R., & Rabelink, T. J. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.5.815 · Cited by 102
Binding Sites for Angiotensin II in Human Mononuclear Leucocytes1
Shimada, K., & Yazaki, Y. (1978) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a132183 · Cited by 79
Masuda, M. O., Levin, M. J., de Oliveira, S. F., Costa, P., Lopez‐Bergami, P., Almeida, N. A. D. S., Pedrosa, R. C., Ferrari, I., Hoebeke, J., & de Carvalho, A. C. C. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.14.1551 · Cited by 59
Self-citationIn Situ Detection of Tissue Factor within the Coronary Intima in Rat Cardiac Allograft Vasculopathy
Hölschermann, H., Bohle, R. M., Zeller, H., Schmidt, H., Stahl, U., Fink, L., Grimm, H., Tillmanns, H., & Haberbosch, W. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65267-4 · Cited by 45
Routine renin-angiotensin system blockade in renal transplantation?
Remuzzi, G., & Perico, N. (2002) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200201000-00001 · Cited by 22
Cited by
Tait, B. D., Süsal, C., Gebel, H. M., Nickerson, P. W., Zachary, A. A., Claas, F. H. J., Reed, E. F., Bray, R. A., Campbell, P., Chapman, J. R., et al. (2013) · Transplantation · doi:10.1097/tp.0b013e31827a19cc · Cited by 787
Angiotensin II revisited: new roles in inflammation, immunology and aging
Benigni, A., Cassis, P., & Remuzzi, G. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000080 · Cited by 757
Loupy, A., Haas, M., Solez, K., Racusen, L., Glotz, D., Seron, D., Nankivell, B. J., Colvin, R. B., Afrouzian, M., Akalin, E., et al. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14107 · Cited by 629
Self-citationRejection of the Kidney Allograft
Nankivell, B. J., & Alexander, S. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0902927 · Cited by 605
Antibody-Mediated Rejection of Solid-Organ Allografts
Loupy, A., & Lefaucheur, C. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1802677 · Cited by 549
Metadata
- Authors
- Dragun, D., Müller, D. N., Bräsen, J. H., Fritsche, L., Nieminen-Kelhä, M., Dechend, R., Kintscher, U., Rudolph, B., Hoebeke, J., Eckert, D., Mazak, I., Plehm, R., Schönemann, C., Unger, T., Budde, K., Neumayer, H.-H., Luft, F. C., & Wallukat, G.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-02-10
- Volume
- 352
- Issue
- 6
- Pages
- 558-569
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1992563074
- Cited by
- 868
- References
- 27
- FWCI
- 18.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.